Find a Test
Our test portfolio includes JOINTstat (14-3-3eta protein test) for diagnosing and managing rheumatoid arthritis, and SPINEstat (Anti-14-3-3eta Multiplex) our first-in-class diagnostic test for axial spondyloarthritis.
14-3-3eta for Rheumatoid Arthritis
United States (US)
14-3-3eta ASRs are available as LDTs at the following labs:
Quest Diagnostics |
|
Test Name |
Test Code |
| 14-3-3eta Protein | 91455 |
Labcorp |
|
Test Name |
Test Code |
| 14-3-3eta Protein | 504550 |
| RheumAssure® (14-3-3eta, RF, anti-CCP) | 504509 |
| RAdx6 Profile (14-3-3eta, RF, anti-CCP, anti-CEP1, anti-Sa, anti-CarP) | 520304 |
| SeroNeg RAdx4 Profile (14-3-3eta, anti-CEP1, anti-Sa, anti-CarP) | 520305 |
| Rheumatoid Arthritis (RA) Profile with Reflex to SeroNeg RAdx4 (RF & anti-CCP, reflex to: 14-3-3eta, anti-CEP1, anti-Sa, anti-CarP) | 520298 |
ARUP Laboratories |
|
Test Name |
Test Code |
| 14-3-3eta Protein | 3017890 |
| Early and Established Rheumatoid Arthritis (RA) Panel (14-3-3eta, RF, anti-CCP) | 3017891 |
COMING SOON
Sonic Healthcare USA |
|
Divisions |
Test Code |
| Clinical Pathology Laboratories | Available Dec 2024 |
| Sunrise Medical Laboratories | Available Dec 2024 |
| East Side Clinical Laboratory | Available Dec 2024 |
| Sonic Reference Laboratory | Available Dec 2024 |
| American Esoteric Laboratories | Available Dec 2024 |
| Pathology Laboratories | Available Dec 2024 |
| Clinical labs of Hawaii | Available Dec 2024 |
Canada
In Canada, JOINTstat® is the Health Canada approved brand name for the 14-3-3η blood test. JOINTstat® is available from Dynacare for RA diagnosis and patient management. For additional information and instructions on how to order the test please contact the Dynacare National Specialty Service Support team at 1-888-988-1888 or email [email protected]
Anti-14-3-3eta Multiplex for Axial Spondyloarthritis
United States (US)
Anti-14-3-3eta Multiplex ASRs are now available for early access in Knoxville, Tennessee through our partnership with New Day Diagnostics as a laboratory developed test (LDT).
Expanded National Access Through Leading Labs in 2025
